ARGENX SE 727.600 € (-4,09 %) D'IETEREN GROUP 175.900 € (+2,03 %) UMICORE 20.540 € (-0,19 %) AZELIS GROUP 13.400 € (+0,75 %) RETAIL ESTATES 62.400 € (-0,32 %) AB INBEV 73.920 € (+1,37 %) KINEPOLIS GROUP 49.850 € (-0,20 %) SYENSQO 81.000 € (-2,41 %) NYRSTAR 0.055 € (+3,77 %) UCB 204.600 € (-0,68 %) KBC ANCORA 96.500 € (+0,63 %) MELEXIS 57.750 € (+1,76 %) TESSENDERLO 18.300 € (-4,09 %) INCLUSIO SA/NV 15.950 € (-0,93 %) MONTEA 62.900 € (-0,47 %) PROXIMUS 6.000 € (+2,13 %) WDP 19.370 € (+0,21 %) ONTEX GROUP 1.786 € (-1,43 %) AGFA-GEVAERT 0.405 € (-1,82 %) BPOST 1.130 € (+2,73 %) TINC 10.540 € (-0,19 %) ORANGE BELGIUM 22.200 € (+0,91 %) IBA 16.380 € (+1,11 %) KBC 121.100 € (+0,37 %) TUBIZE-FIN 172.800 € (-0,75 %) ASCENCIO 52.500 € (-0,19 %) ECONOCOM GROUP 1.360 € (-2,86 %) ACKERMANS V.HAAREN 263.000 € (+1,08 %) NEXTENSA 44.400 € (+0,52 %) VGP 62.600 € (-0,32 %) ACCENTIS 0.027 € (+3,92 %) AGEAS 74.200 € (+0,88 %) WERELDHAVE BELGIUM 50.600 € (+1,20 %) GIMV 47.650 € (+0,11 %) SOLVAY 25.180 € (+0,24 %) VASTNED 27.900 € (+0,72 %) SIPEF 111.400 € (-1,07 %) SOFINA 259.400 € (+0,31 %) CIE BOIS SAUVAGE 276.000 € (-0,72 %) BARCO 7.155 € (+2,80 %) CFE 11.400 € (-2,98 %) BREDERODE 97.000 € (-0,41 %) EKOPAK 2.400 € (-2,04 %) ONWARD MEDICAL 2.345 € (-0,64 %) NYXOAH 1.000 € (-6,72 %) CAMPINE 176.500 € (+0,86 %) COLRUYT 35.660 € (-0,17 %) ENERGYVISION 17.940 € (-1,32 %) HOME INVEST BE. 17.860 € (-0,22 %) VAN DE VELDE 29.300 € (-0,34 %) ELIA GROUP 123.700 € (+1,98 %) FAGRON 23.500 € (+3,30 %) FLUXYS BELGIUM D 20.700 € (0,00 %) XIOR 23.750 € (+0,64 %) BEKAERT 39.800 € (+1,14 %) DEME GROUP 167.400 € (+0,12 %) CENERGY 21.800 € (+0,09 %) EVS 19.480 € (+0,62 %) AEDIFICA 62.950 € (-0,08 %) BIOTALYS 1.740 € (+0,58 %)
AXA 42.970 € (+0,28 %)
EUROPLASMA 0.000 € (0,00 %)
LVMH 397.000 € (-0,33 %)
SAFRAN 317.000 € (0,00 %)
SAINT GOBAIN 66.540 € (0,00 %)
FORVIA 9.018 € (+2,50 %)
SANOFI 71.940 € (-0,30 %)
SBM OFFSHORE 35.320 € (+2,44 %)
DBT 0.061 € (0,00 %)
L'OREAL 407.400 € (+0,14 %)
CARREFOUR 16.610 € (-0,24 %)
PUBLICIS GROUPE SA 102.450 € (-1,25 %)
NN GROUP 76.460 € (+0,92 %)
TRACTIAL 2.580 € (+26,16 %)
CALIBRE 0.000 € (0,00 %)
RENAULT 27.590 € (+3,33 %)
STMICROELECTRONICS 41.170 € (-0,58 %)
SCOR SE 33.760 € (+1,08 %)
PLANISWARE 25.900 € (-1,89 %)
ENGIE 23.420 € (+0,90 %)
VALEO 13.950 € (+1,86 %)
DASSAULT AVIATION 303.800 € (+1,95 %)
UMG 16.265 € (+4,30 %)
SOCIETE GENERALE 64.470 € (-0,20 %)
SHELL PLC 46.880 € (+1,09 %)
BRUNEL INTERNAT 6.950 € (-0,86 %)
BANIJAY GROUP 8.000 € (-2,20 %)
MAUNA KEA TECH 0.114 € (+3,64 %)
SIGNIFY NV 14.590 € (+0,69 %)
KERING 216.950 € (+0,51 %)
VEOLIA ENVIRON. 32.400 € (+0,06 %)
EUROCASTLE INVEST. 14.000 € (+18,64 %)
CREDIT AGRICOLE 15.715 € (+0,45 %)
HEIJMANS KON 82.700 € (+3,25 %)
DSM FIRMENICH AG 107.050 € (-0,37 %)
AKZO NOBEL 59.020 € (-0,24 %)
CHRISTIAN DIOR 433.200 € (+0,46 %)
PHILIPS KON 23.160 € (+1,94 %)
ASML HOLDING 1 477.200 € (+0,89 %)
TECHNIP ENERGIES 30.980 € (+3,47 %)
RELX 34.680 € (+1,29 %)
UNILEVER 58.950 € (+1,38 %)
ORANGE 14.565 € (+0,87 %)
LEGRAND 134.000 € (+0,22 %)
UPERGY 1.645 € (+0,30 %)
LHYFE 1.644 € (-0,36 %)
CORBION 23.120 € (+0,09 %)
PROSUS 35.960 € (+0,03 %)
ARCELORMITTAL SA 56.800 € (+0,21 %)
KPN KON 4.088 € (+1,36 %)
FUGRO 7.315 € (+2,88 %)
BOUYGUES 41.510 € (+1,39 %)
ING GROEP N.V. 30.060 € (+1,49 %)
ENVIPCO HOLDING 3.430 € (0,00 %)
BE SEMICONDUCTOR 155.550 € (-4,80 %)
MEDINCELL 25.720 € (-2,28 %)
AALBERTS NV 41.420 € (+1,07 %)
HAFFNER ENERGY 0.700 € (-4,63 %)
2CRSI 26.240 € (-1,94 %)
DBV TECHNOLOGIES 1.568 € (-3,39 %) News Réglementées
|
16/10/2026 17:42
EQS-Adhoc: FamiCord AG: intends capital increase of up to 20 percent against cash contri-butions with subscription rightsEQS-Ad-hoc: FamiCord AG / Key word(s): Capital measures / Capital increase Leipzig, 16 October 2026 – FamiCord AG (ISIN: DE000A0BL849) intends to carry out a capital increase by partially utilizing the Authorized Capital 2024/1 through the issuance of new shares representing up to 20 percent of the Company’s existing share capital. The new shares shall be offered for subscription to the Company’s shareholders. The Company targets gross proceeds from the capital increase of up to EUR 9 million. These proceeds shall be used primarily to stabilize and optimize the core business of cell and tissue banking as well as CDMO activities, to streamline the Group’s structure – including related reorganization and efficiency measures – and to evaluate and selectively pursue growth opportunities in adjacent business areas. The subscription offer is intended to be launched in November 2026. Further details of the capital increase will be announced following the final resolutions of the Management Board and Supervisory Board. Notifying Person: Jakub Baran (CEO) DISCLAIMER This announcement may not be distributed or published in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other jurisdiction in which such distribution or publication would be unlawful. The distribution of this publication may be restricted by law in certain jurisdictions and anyone in possession of this document or information referred to herein should inform themselves about and observe any such restrictions. Failure to comply with such restrictions may constitute a violation of the capital market laws of such countries. This announcement does not constitute an offer of, or an invitation to subscribe for or purchase, securities of FamiCord AG in the United States of America, Germany or any other jurisdiction. No public offering has been or will be made and no prospectus has been or will be published in connection with the transaction. Neither this publication nor its contents may form the basis of an offer in any jurisdiction. The securities referred to above may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities of FamiCord AG have not been and will not be registered under the Securities Act. This announcement does not constitute a recommendation regarding the placement of the securities described in this announcement. Investors should consult a professional adviser as to the suitability of the offer for the person concerned. In the United Kingdom, this publication is directed only at (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, partnerships, etc.) (all such persons together being referred to as "Relevant Persons"). This publication must not be acted on or relied on by persons other than Relevant Persons. Any investment or investment opportunity referred to in this publication is available only to Relevant Persons and will be engaged in only with Relevant Persons. The offer referred to herein, which is being made in Member States of the European Economic Area (each a "Relevant Member State"), is directed only at "qualified investors" as defined in Article 2(e) of the Prospectus Regulation ("Qualified Investors"). For these purposes, the term "Prospectus Regulation" means Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC and includes the related delegated regulations. No action has been taken that would permit an offering of the securities, their acquisition or the distribution of this publication in countries where this is not permitted. Any person into whose possession this publication comes is required to inform themselves about and to observe any such restrictions. OTHER This publication constitutes neither an offer to sell nor a solicitation to buy securities. This announcement may not be distributed or published in the United States of America (including its territories and possessions), Canada, Japan or Australia or any other jurisdiction in which such publication would be unlawful. This announcement does not constitute a recommendation to buy or sell the securities described in this announcement. End of Inside Information 16-Oct-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2417458 16-Oct-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière